Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO7856.3 | Streptomyces halstedii atcc 55794 | Subspecies | Streptomycetaceae | Bacteria | StreptomeDB* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | > | 600 | mg/kg | 2724304 |
NPT32 | Organism | Mus musculus | Mus musculus | TD50 | = | 47 | mg/kg | 2724304 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.197 | ug/ml | 2724304 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.13 | ug/ml | 2724304 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.162 | ug/ml | 2724304 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.097 | ug/ml | 2724304 |
NPT997 | Protein Complex | GABA-B receptor | Homo sapiens | IC50 | = | 35 | nM | 7650684 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | IC50 | = | 1047000 | nM | 7650684 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 107 | nM | 7650684 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 24 | uM/kg | 7650684 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 52 | uM/kg | 7650684 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | IC50 | = | 30 | nM | 2995665 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 60 | nM | 2995665 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 1800 | nM | 2995665 |
NPT1774 | Protein Family | Sodium channel alpha subunits; brain (Types I, II, III) | Homo sapiens | Inhibition | = | 6.2 | % | 2579237 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 30 | nM | 10.1016/S0960-894X(01)81218-X |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 200 | nM | 3031294 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 420 | nM | 1849996 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 330 | nM | 1652022 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 180 | nM | 1652022 |
NPT995 | Protein Complex | GABA B receptor | Rattus norvegicus | IC50 | = | 200 | nM | 10.1016/0960-894X(96)00307-1 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | IC50 | = | 6400 | nM | 10.1016/0960-894X(96)00307-1 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | Inhibition | = | 75 | % | 10.1016/0960-894X(96)00307-1 |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | IC50 | = | 50 | nM | 16250647 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 20.24 | min | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 35.23 | min | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 30.21 | m | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 28.48 | m | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 30.76 | m | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 35.64 | m | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 214 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 50 | % | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 225 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 234 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 254 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 52 | % | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 53 | % | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 13.42 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 15.35 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 14.36 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 14.22 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 125.34 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 121.46 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 121.44 | s | 18693017 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 128.56 | s | 18693017 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | 20.7 | % | 18788725 |
NPT2 | Others | Unspecified | Ki | = | 220 | nM | 18578471 | |
NPT2 | Others | Unspecified | EC50 | = | 750 | nM | 18578471 | |
NPT664 | Protein Family | Histone deacetylase | Homo sapiens | Activity | = | 98 | % | 19520580 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 199.5 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 31.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 44668.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 9200 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 580.4 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 756.9 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 6510.4 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 5358.2 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 9.5 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 16833.6 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 106.2 | nM | PubChem BioAssay data set | |
NPT667 | Individual Protein | Solute carrier family 22 member 8 | Rattus norvegicus | Activity | = | 23.2 | % | 12679720 |
NPT667 | Individual Protein | Solute carrier family 22 member 8 | Rattus norvegicus | Activity | = | 25.7 | % | 12358729 |
NPT899 | Protein Complex | GABA-A receptor; alpha-1/beta-2/gamma-2 | Rattus norvegicus | EC50 | > | 100000 | nM | 23428109 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 26.3 | ug | 23428109 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 8.1 | ug | 23428109 |
NPT997 | Protein Complex | GABA-B receptor | Homo sapiens | EC50 | = | 1700 | nM | 23428109 |
NPT2 | Others | Unspecified | IC50 | = | 360 | nM | 23886812 | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 80.8 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 102.22 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 22387.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3162.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 112.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 10 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 3.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 0.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 98.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 15.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 0.2 | nM | PubChem BioAssay data set | ||
NPT997 | Protein Complex | GABA-B receptor | Homo sapiens | Ki | = | 6000 | nM | 25856547 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC313981 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8113 | Intermediate Similarity | NPC122493 |
0.8113 | Intermediate Similarity | NPC293628 |
0.8113 | Intermediate Similarity | NPC10781 |
0.7944 | Intermediate Similarity | NPC324569 |
0.7627 | Intermediate Similarity | NPC471318 |
0.7611 | Intermediate Similarity | NPC67043 |
0.7589 | Intermediate Similarity | NPC164859 |
0.7391 | Intermediate Similarity | NPC327481 |
0.7321 | Intermediate Similarity | NPC12730 |
0.7311 | Intermediate Similarity | NPC474584 |
0.7308 | Intermediate Similarity | NPC48909 |
0.7288 | Intermediate Similarity | NPC319579 |
0.7264 | Intermediate Similarity | NPC322387 |
0.7255 | Intermediate Similarity | NPC127343 |
0.7227 | Intermediate Similarity | NPC329011 |
0.7212 | Intermediate Similarity | NPC44830 |
0.713 | Intermediate Similarity | NPC471310 |
0.7064 | Intermediate Similarity | NPC274455 |
0.7064 | Intermediate Similarity | NPC70940 |
0.7064 | Intermediate Similarity | NPC86670 |
0.7048 | Intermediate Similarity | NPC285773 |
0.6992 | Remote Similarity | NPC197470 |
0.6937 | Remote Similarity | NPC323164 |
0.6935 | Remote Similarity | NPC188867 |
0.6935 | Remote Similarity | NPC106551 |
0.6935 | Remote Similarity | NPC281686 |
0.693 | Remote Similarity | NPC322598 |
0.6916 | Remote Similarity | NPC95965 |
0.6881 | Remote Similarity | NPC329064 |
0.6838 | Remote Similarity | NPC291426 |
0.6807 | Remote Similarity | NPC274089 |
0.6807 | Remote Similarity | NPC191215 |
0.6788 | Remote Similarity | NPC316906 |
0.678 | Remote Similarity | NPC324786 |
0.6777 | Remote Similarity | NPC216122 |
0.6777 | Remote Similarity | NPC158854 |
0.6774 | Remote Similarity | NPC113099 |
0.6772 | Remote Similarity | NPC239697 |
0.6727 | Remote Similarity | NPC325441 |
0.6719 | Remote Similarity | NPC478016 |
0.6719 | Remote Similarity | NPC478014 |
0.6719 | Remote Similarity | NPC478015 |
0.6696 | Remote Similarity | NPC86987 |
0.6695 | Remote Similarity | NPC471317 |
0.6693 | Remote Similarity | NPC317784 |
0.6693 | Remote Similarity | NPC314992 |
0.6693 | Remote Similarity | NPC142638 |
0.6692 | Remote Similarity | NPC35996 |
0.6667 | Remote Similarity | NPC326079 |
0.6667 | Remote Similarity | NPC2265 |
0.6667 | Remote Similarity | NPC172925 |
0.6607 | Remote Similarity | NPC258627 |
0.6589 | Remote Similarity | NPC80150 |
0.6583 | Remote Similarity | NPC476198 |
0.6579 | Remote Similarity | NPC246757 |
0.6579 | Remote Similarity | NPC291070 |
0.6574 | Remote Similarity | NPC288903 |
0.6562 | Remote Similarity | NPC310467 |
0.6552 | Remote Similarity | NPC477767 |
0.6549 | Remote Similarity | NPC317645 |
0.6541 | Remote Similarity | NPC477937 |
0.6525 | Remote Similarity | NPC128248 |
0.6525 | Remote Similarity | NPC136810 |
0.6525 | Remote Similarity | NPC264728 |
0.6525 | Remote Similarity | NPC225079 |
0.6525 | Remote Similarity | NPC133809 |
0.6522 | Remote Similarity | NPC215351 |
0.6522 | Remote Similarity | NPC20142 |
0.6489 | Remote Similarity | NPC27581 |
0.6484 | Remote Similarity | NPC169328 |
0.6471 | Remote Similarity | NPC304873 |
0.6466 | Remote Similarity | NPC261947 |
0.6462 | Remote Similarity | NPC190663 |
0.646 | Remote Similarity | NPC316108 |
0.646 | Remote Similarity | NPC84288 |
0.6455 | Remote Similarity | NPC294134 |
0.6417 | Remote Similarity | NPC329556 |
0.6404 | Remote Similarity | NPC110704 |
0.6373 | Remote Similarity | NPC229235 |
0.637 | Remote Similarity | NPC58827 |
0.637 | Remote Similarity | NPC307437 |
0.637 | Remote Similarity | NPC72473 |
0.6364 | Remote Similarity | NPC84281 |
0.6364 | Remote Similarity | NPC169485 |
0.6364 | Remote Similarity | NPC160493 |
0.6364 | Remote Similarity | NPC317474 |
0.6364 | Remote Similarity | NPC291027 |
0.6364 | Remote Similarity | NPC329282 |
0.6364 | Remote Similarity | NPC213126 |
0.6356 | Remote Similarity | NPC290515 |
0.6356 | Remote Similarity | NPC271475 |
0.6356 | Remote Similarity | NPC164514 |
0.6356 | Remote Similarity | NPC120393 |
0.6356 | Remote Similarity | NPC108606 |
0.6356 | Remote Similarity | NPC226096 |
0.6356 | Remote Similarity | NPC229242 |
0.6356 | Remote Similarity | NPC303611 |
0.6333 | Remote Similarity | NPC475978 |
0.6333 | Remote Similarity | NPC474820 |
0.6328 | Remote Similarity | NPC188010 |
0.6325 | Remote Similarity | NPC469893 |
0.6324 | Remote Similarity | NPC16031 |
0.6324 | Remote Similarity | NPC161593 |
0.6324 | Remote Similarity | NPC145888 |
0.6311 | Remote Similarity | NPC474559 |
0.6311 | Remote Similarity | NPC155429 |
0.6308 | Remote Similarity | NPC229353 |
0.6303 | Remote Similarity | NPC217621 |
0.6296 | Remote Similarity | NPC192623 |
0.6296 | Remote Similarity | NPC309279 |
0.6294 | Remote Similarity | NPC57976 |
0.6286 | Remote Similarity | NPC276699 |
0.6283 | Remote Similarity | NPC12429 |
0.6283 | Remote Similarity | NPC477693 |
0.6283 | Remote Similarity | NPC477704 |
0.6281 | Remote Similarity | NPC255676 |
0.6281 | Remote Similarity | NPC202613 |
0.6277 | Remote Similarity | NPC325651 |
0.6273 | Remote Similarity | NPC270507 |
0.6271 | Remote Similarity | NPC469892 |
0.6271 | Remote Similarity | NPC226041 |
0.6271 | Remote Similarity | NPC469891 |
0.6271 | Remote Similarity | NPC469890 |
0.6269 | Remote Similarity | NPC317758 |
0.6261 | Remote Similarity | NPC226438 |
0.6261 | Remote Similarity | NPC187725 |
0.6261 | Remote Similarity | NPC141607 |
0.626 | Remote Similarity | NPC94751 |
0.626 | Remote Similarity | NPC142326 |
0.626 | Remote Similarity | NPC244933 |
0.626 | Remote Similarity | NPC85560 |
0.626 | Remote Similarity | NPC319950 |
0.625 | Remote Similarity | NPC94487 |
0.6239 | Remote Similarity | NPC161972 |
0.6239 | Remote Similarity | NPC303045 |
0.6231 | Remote Similarity | NPC476440 |
0.623 | Remote Similarity | NPC19136 |
0.6228 | Remote Similarity | NPC9822 |
0.6228 | Remote Similarity | NPC470877 |
0.6218 | Remote Similarity | NPC160548 |
0.6218 | Remote Similarity | NPC175852 |
0.6218 | Remote Similarity | NPC317280 |
0.6218 | Remote Similarity | NPC329387 |
0.6218 | Remote Similarity | NPC210529 |
0.6198 | Remote Similarity | NPC327226 |
0.6198 | Remote Similarity | NPC318154 |
0.6198 | Remote Similarity | NPC284477 |
0.6198 | Remote Similarity | NPC25458 |
0.6195 | Remote Similarity | NPC471638 |
0.619 | Remote Similarity | NPC122327 |
0.619 | Remote Similarity | NPC113000 |
0.619 | Remote Similarity | NPC112609 |
0.6186 | Remote Similarity | NPC3371 |
0.6186 | Remote Similarity | NPC25565 |
0.6183 | Remote Similarity | NPC237420 |
0.6182 | Remote Similarity | NPC103387 |
0.6182 | Remote Similarity | NPC323103 |
0.6179 | Remote Similarity | NPC105899 |
0.6179 | Remote Similarity | NPC321670 |
0.6174 | Remote Similarity | NPC471307 |
0.6174 | Remote Similarity | NPC74936 |
0.6174 | Remote Similarity | NPC159178 |
0.6174 | Remote Similarity | NPC78041 |
0.6174 | Remote Similarity | NPC62765 |
0.6174 | Remote Similarity | NPC209764 |
0.6174 | Remote Similarity | NPC141139 |
0.6174 | Remote Similarity | NPC121872 |
0.6172 | Remote Similarity | NPC35850 |
0.6172 | Remote Similarity | NPC276949 |
0.617 | Remote Similarity | NPC314835 |
0.6168 | Remote Similarity | NPC298023 |
0.6168 | Remote Similarity | NPC290638 |
0.6167 | Remote Similarity | NPC221825 |
0.6167 | Remote Similarity | NPC7435 |
0.6167 | Remote Similarity | NPC125732 |
0.6167 | Remote Similarity | NPC245561 |
0.6165 | Remote Similarity | NPC71684 |
0.6148 | Remote Similarity | NPC68055 |
0.6148 | Remote Similarity | NPC222466 |
0.6147 | Remote Similarity | NPC121800 |
0.6143 | Remote Similarity | NPC88667 |
0.6134 | Remote Similarity | NPC475439 |
0.6134 | Remote Similarity | NPC473501 |
0.6134 | Remote Similarity | NPC253423 |
0.6131 | Remote Similarity | NPC321561 |
0.6129 | Remote Similarity | NPC37914 |
0.6124 | Remote Similarity | NPC33742 |
0.6121 | Remote Similarity | NPC245259 |
0.6119 | Remote Similarity | NPC142577 |
0.6116 | Remote Similarity | NPC473325 |
0.6116 | Remote Similarity | NPC282895 |
0.6116 | Remote Similarity | NPC52472 |
0.6115 | Remote Similarity | NPC473247 |
0.6111 | Remote Similarity | NPC103488 |
0.6111 | Remote Similarity | NPC224544 |
0.6103 | Remote Similarity | NPC101719 |
0.6103 | Remote Similarity | NPC47667 |
0.6102 | Remote Similarity | NPC58674 |
0.6102 | Remote Similarity | NPC206764 |
0.6098 | Remote Similarity | NPC226778 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC313981 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD189 | Phase 3 |
1.0 | High Similarity | NPD188 | Approved |
0.8922 | High Similarity | NPD253 | Approved |
0.8305 | Intermediate Similarity | NPD3603 | Phase 3 |
0.8113 | Intermediate Similarity | NPD9566 | Approved |
0.7963 | Intermediate Similarity | NPD3097 | Clinical (unspecified phase) |
0.7815 | Intermediate Similarity | NPD2617 | Discontinued |
0.7559 | Intermediate Similarity | NPD1974 | Clinical (unspecified phase) |
0.7434 | Intermediate Similarity | NPD1415 | Approved |
0.7213 | Intermediate Similarity | NPD5162 | Approved |
0.719 | Intermediate Similarity | NPD747 | Discontinued |
0.7184 | Intermediate Similarity | NPD226 | Approved |
0.7143 | Intermediate Similarity | NPD3643 | Approved |
0.7143 | Intermediate Similarity | NPD3644 | Approved |
0.7143 | Intermediate Similarity | NPD3642 | Approved |
0.7132 | Intermediate Similarity | NPD3935 | Phase 3 |
0.7107 | Intermediate Similarity | NPD1373 | Approved |
0.7107 | Intermediate Similarity | NPD1374 | Approved |
0.7107 | Intermediate Similarity | NPD1371 | Approved |
0.7107 | Intermediate Similarity | NPD1370 | Approved |
0.7107 | Intermediate Similarity | NPD3598 | Phase 3 |
0.7099 | Intermediate Similarity | NPD5246 | Clinical (unspecified phase) |
0.708 | Intermediate Similarity | NPD168 | Phase 1 |
0.708 | Intermediate Similarity | NPD167 | Phase 2 |
0.7064 | Intermediate Similarity | NPD1089 | Approved |
0.7064 | Intermediate Similarity | NPD1086 | Approved |
0.7064 | Intermediate Similarity | NPD1090 | Approved |
0.7048 | Intermediate Similarity | NPD262 | Approved |
0.7048 | Intermediate Similarity | NPD263 | Approved |
0.7048 | Intermediate Similarity | NPD9491 | Approved |
0.7015 | Intermediate Similarity | NPD1228 | Phase 2 |
0.6992 | Remote Similarity | NPD1348 | Approved |
0.6972 | Remote Similarity | NPD800 | Approved |
0.6972 | Remote Similarity | NPD5346 | Phase 2 |
0.6972 | Remote Similarity | NPD5347 | Phase 2 |
0.6944 | Remote Similarity | NPD4793 | Discontinued |
0.6942 | Remote Similarity | NPD9508 | Approved |
0.6942 | Remote Similarity | NPD3651 | Discontinued |
0.6937 | Remote Similarity | NPD1088 | Approved |
0.6935 | Remote Similarity | NPD9568 | Approved |
0.6929 | Remote Similarity | NPD3881 | Discontinued |
0.6912 | Remote Similarity | NPD2830 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD3934 | Clinical (unspecified phase) |
0.6911 | Remote Similarity | NPD1023 | Approved |
0.6911 | Remote Similarity | NPD1020 | Approved |
0.6911 | Remote Similarity | NPD1022 | Approved |
0.6911 | Remote Similarity | NPD1021 | Approved |
0.6905 | Remote Similarity | NPD1855 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD5981 | Approved |
0.6893 | Remote Similarity | NPD225 | Approved |
0.6893 | Remote Similarity | NPD227 | Approved |
0.6891 | Remote Similarity | NPD1401 | Approved |
0.6875 | Remote Similarity | NPD5122 | Clinical (unspecified phase) |
0.687 | Remote Similarity | NPD523 | Approved |
0.687 | Remote Similarity | NPD524 | Approved |
0.6864 | Remote Similarity | NPD1040 | Phase 2 |
0.6847 | Remote Similarity | NPD1239 | Approved |
0.6846 | Remote Similarity | NPD2031 | Discontinued |
0.6842 | Remote Similarity | NPD1076 | Approved |
0.6833 | Remote Similarity | NPD476 | Approved |
0.6822 | Remote Similarity | NPD3880 | Clinical (unspecified phase) |
0.6822 | Remote Similarity | NPD1077 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD4452 | Approved |
0.6815 | Remote Similarity | NPD4453 | Approved |
0.6814 | Remote Similarity | NPD1693 | Approved |
0.6812 | Remote Similarity | NPD1209 | Approved |
0.6812 | Remote Similarity | NPD1205 | Approved |
0.6812 | Remote Similarity | NPD989 | Approved |
0.6797 | Remote Similarity | NPD2956 | Clinical (unspecified phase) |
0.6789 | Remote Similarity | NPD1087 | Approved |
0.6788 | Remote Similarity | NPD7231 | Approved |
0.6788 | Remote Similarity | NPD7230 | Approved |
0.6777 | Remote Similarity | NPD1756 | Approved |
0.6777 | Remote Similarity | NPD1752 | Approved |
0.6774 | Remote Similarity | NPD1075 | Approved |
0.6774 | Remote Similarity | NPD1074 | Approved |
0.6774 | Remote Similarity | NPD1073 | Approved |
0.6772 | Remote Similarity | NPD4504 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD4069 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD4065 | Approved |
0.6765 | Remote Similarity | NPD4067 | Approved |
0.6765 | Remote Similarity | NPD4066 | Approved |
0.6765 | Remote Similarity | NPD4068 | Approved |
0.6721 | Remote Similarity | NPD801 | Discontinued |
0.672 | Remote Similarity | NPD255 | Approved |
0.672 | Remote Similarity | NPD256 | Approved |
0.6718 | Remote Similarity | NPD3098 | Discontinued |
0.6714 | Remote Similarity | NPD5170 | Discontinued |
0.6696 | Remote Similarity | NPD1564 | Approved |
0.6696 | Remote Similarity | NPD1566 | Phase 3 |
0.6696 | Remote Similarity | NPD1565 | Approved |
0.6693 | Remote Similarity | NPD2217 | Approved |
0.6693 | Remote Similarity | NPD2218 | Phase 2 |
0.6692 | Remote Similarity | NPD5335 | Discontinued |
0.6667 | Remote Similarity | NPD9490 | Approved |
0.6667 | Remote Similarity | NPD2657 | Approved |
0.6667 | Remote Similarity | NPD688 | Clinical (unspecified phase) |
0.6641 | Remote Similarity | NPD182 | Clinical (unspecified phase) |
0.6641 | Remote Similarity | NPD6994 | Approved |
0.6641 | Remote Similarity | NPD6993 | Approved |
0.6641 | Remote Similarity | NPD2371 | Approved |
0.6614 | Remote Similarity | NPD828 | Approved |
0.6607 | Remote Similarity | NPD3672 | Approved |
0.6607 | Remote Similarity | NPD3673 | Approved |
0.6597 | Remote Similarity | NPD1553 | Approved |
0.6594 | Remote Similarity | NPD1207 | Approved |
0.6594 | Remote Similarity | NPD1206 | Approved |
0.6593 | Remote Similarity | NPD1070 | Approved |
0.6593 | Remote Similarity | NPD1069 | Approved |
0.6583 | Remote Similarity | NPD1766 | Approved |
0.6583 | Remote Similarity | NPD1018 | Approved |
0.6583 | Remote Similarity | NPD1765 | Approved |
0.6583 | Remote Similarity | NPD1767 | Approved |
0.6583 | Remote Similarity | NPD1761 | Approved |
0.6583 | Remote Similarity | NPD1763 | Approved |
0.6581 | Remote Similarity | NPD1067 | Discontinued |
0.6581 | Remote Similarity | NPD2066 | Phase 3 |
0.656 | Remote Similarity | NPD2650 | Approved |
0.656 | Remote Similarity | NPD2652 | Approved |
0.6544 | Remote Similarity | NPD2078 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD4879 | Approved |
0.6538 | Remote Similarity | NPD1302 | Clinical (unspecified phase) |
0.6532 | Remote Similarity | NPD2499 | Approved |
0.6532 | Remote Similarity | NPD2500 | Approved |
0.6529 | Remote Similarity | NPD448 | Clinical (unspecified phase) |
0.6529 | Remote Similarity | NPD449 | Clinical (unspecified phase) |
0.6525 | Remote Similarity | NPD7611 | Approved |
0.6522 | Remote Similarity | NPD2656 | Approved |
0.6522 | Remote Similarity | NPD2655 | Approved |
0.6515 | Remote Similarity | NPD4677 | Discontinued |
0.6491 | Remote Similarity | NPD1812 | Approved |
0.6491 | Remote Similarity | NPD1814 | Approved |
0.6489 | Remote Similarity | NPD4761 | Approved |
0.6489 | Remote Similarity | NPD4762 | Approved |
0.6489 | Remote Similarity | NPD4706 | Clinical (unspecified phase) |
0.6489 | Remote Similarity | NPD1703 | Clinical (unspecified phase) |
0.648 | Remote Similarity | NPD2607 | Approved |
0.6471 | Remote Similarity | NPD9722 | Approved |
0.6471 | Remote Similarity | NPD9721 | Approved |
0.6466 | Remote Similarity | NPD4382 | Clinical (unspecified phase) |
0.6466 | Remote Similarity | NPD196 | Phase 1 |
0.6462 | Remote Similarity | NPD1320 | Phase 1 |
0.6452 | Remote Similarity | NPD5927 | Discontinued |
0.6439 | Remote Similarity | NPD3072 | Approved |
0.6439 | Remote Similarity | NPD3073 | Approved |
0.6439 | Remote Similarity | NPD1360 | Approved |
0.6439 | Remote Similarity | NPD4878 | Approved |
0.6439 | Remote Similarity | NPD3071 | Approved |
0.6435 | Remote Similarity | NPD1563 | Approved |
0.6435 | Remote Similarity | NPD1066 | Discontinued |
0.6434 | Remote Similarity | NPD6093 | Discontinued |
0.6423 | Remote Similarity | NPD5422 | Clinical (unspecified phase) |
0.6418 | Remote Similarity | NPD6565 | Approved |
0.6418 | Remote Similarity | NPD1321 | Clinical (unspecified phase) |
0.6418 | Remote Similarity | NPD6563 | Approved |
0.6418 | Remote Similarity | NPD6564 | Approved |
0.6417 | Remote Similarity | NPD1929 | Approved |
0.6417 | Remote Similarity | NPD1931 | Clinical (unspecified phase) |
0.6417 | Remote Similarity | NPD1930 | Approved |
0.6415 | Remote Similarity | NPD9563 | Approved |
0.6415 | Remote Similarity | NPD9564 | Approved |
0.6415 | Remote Similarity | NPD79 | Approved |
0.6406 | Remote Similarity | NPD4574 | Approved |
0.6406 | Remote Similarity | NPD4576 | Approved |
0.6405 | Remote Similarity | NPD3790 | Phase 2 |
0.6403 | Remote Similarity | NPD2863 | Approved |
0.6393 | Remote Similarity | NPD467 | Phase 1 |
0.6364 | Remote Similarity | NPD3974 | Phase 2 |
0.6364 | Remote Similarity | NPD2609 | Approved |
0.6364 | Remote Similarity | NPD2612 | Approved |
0.6364 | Remote Similarity | NPD2611 | Approved |
0.6364 | Remote Similarity | NPD2608 | Approved |
0.6364 | Remote Similarity | NPD2610 | Approved |
0.6364 | Remote Similarity | NPD3132 | Approved |
0.6364 | Remote Similarity | NPD4215 | Approved |
0.6364 | Remote Similarity | NPD4216 | Approved |
0.6364 | Remote Similarity | NPD4217 | Approved |
0.6364 | Remote Similarity | NPD3131 | Approved |
0.6364 | Remote Similarity | NPD4218 | Approved |
0.6356 | Remote Similarity | NPD466 | Approved |
0.6356 | Remote Similarity | NPD9612 | Approved |
0.6356 | Remote Similarity | NPD9609 | Approved |
0.6356 | Remote Similarity | NPD9611 | Approved |
0.6349 | Remote Similarity | NPD181 | Approved |
0.6346 | Remote Similarity | NPD2350 | Clinical (unspecified phase) |
0.6345 | Remote Similarity | NPD5166 | Discontinued |
0.6343 | Remote Similarity | NPD1574 | Approved |
0.6341 | Remote Similarity | NPD9532 | Phase 3 |
0.6336 | Remote Similarity | NPD4164 | Clinical (unspecified phase) |
0.6333 | Remote Similarity | NPD1932 | Approved |
0.6325 | Remote Similarity | NPD5206 | Clinical (unspecified phase) |
0.6324 | Remote Similarity | NPD1050 | Approved |
0.6324 | Remote Similarity | NPD7828 | Discontinued |
0.6324 | Remote Similarity | NPD9569 | Approved |
0.6323 | Remote Similarity | NPD4532 | Approved |
0.6312 | Remote Similarity | NPD4448 | Approved |
0.6312 | Remote Similarity | NPD4449 | Approved |
0.6311 | Remote Similarity | NPD999 | Phase 2 |
0.6304 | Remote Similarity | NPD5581 | Approved |
0.6299 | Remote Similarity | NPD1681 | Approved |
Molecular Weight:   | 213.06 |
ALogP:   | -0.5051 |
MLogP:   | 2.12 |
XLogP:   | 1.577 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 63.32 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 14 |